Brief: Microba Life Sciences Posts H1 Revenue Of A$8.08M
29/01/2025 01:20
Jan 29 (Reuters) - Microba Life Sciences Ltd MAP.AX :
* H1 FY25 REVENUE OF A$8.08M
Further company coverage: MAP.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Microba Life Sciences
See all newsAustralia's Microba Life Sciences slumps to record low on discounted placement
Brief: Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per Share
Brief: Microba Life Sciences Seeks Trading Halt
Brief: Microba Life Sciences Logs Qtrly Total Revenue A$3.36 Mln
Brief: Microba Life Sciences Posts HY Loss Attributable A$10.6 Million